Difference in clearance of exogenously administered smooth-form LPS following host responses among normal, sensitized and LPS-tolerant mice

Innate Immunity

Volumn 4, Issue 6, 1997, Pages 415-423

  Morita, H ^a   Hasunuma, R ^b   Hoshino, M ^b   Fujihara, M ^b   Tanaka, S ^a   Yamamoto, S ^c   Kumazawa, Y ^b  

^a SEIKAGAKU CORPORATION   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c Ohita Medical College   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79958241852     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/096805199700400605     Document Type: Article

References (27)

1. Morita H., Hasunuma R., Fujihara M.et al.Measurement of different types of endotoxin in murine plasma by pretreatment with alkaline reagent and kinetic chromogenic Limulus test. J Endotoxin Res 1997; 4: 339-346.
2. Freudenberg M.A., Kleine B., Freudenberg N., Galanos C. Distribution, degradation and elimination of intravenously applied lipopolysaccharide in rats. In: Homma J.Y., Kanegasaki S., Lüderitz O., Shiba T., Westphal O. (eds) Bacterial Endotoxin- Chemical, Biological and Clinical Aspects. Weinheim: Verlag Chemie, 1984; 295-304.
3. Freudenberg M.A. Galanos C. Metabolism of LPS in vivo. In: Morrison D.C., Ryan J.L. (eds) Bacterial Endotoxic Lipopolysaccharides, Vol. 2. Boca Raton: CRC Press, 1992; 275-294.
4. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD 14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431-1433.
5. Tobias P.S., Soldau K., Gegner J.A., Mintz D., Ulevitch R.J. Lipopolysaccharide binding protein mediated complexation of lipopolysaccharide with soluble CD 14. J Biol Chem 1995; 270: 10482-10488.
6. Tobias P.S., Soldau K., Ulevitch R.J. Isolation of a lipopolysaccharide binding acute phase reactant from rabbit serum. J Exp Med 1986; 164: 777-793.
7. Wurfel M.M., Kunitake S.T., Lichenstein H., Kane J.P., Wright S.D. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp Med 1994; 180: 1025-1035.
8. Galanos C., Freudenberg M.A., Katschinski T., Salomao R., Mossmann H., Kumazawa Y. Tumor necrosis factor and host response to endotoxin. In: Morrison D.C., Ryan J.L. (eds) Bacterial Endotoxic Lipopolysaccharides, Vol. II. Boca Raton: CRC Press, 1992; 75-104.
9. Galanos C., Freudenberg M.A. Bacterial lipopolysaccharides: structure, metabolism and mechanisms of action. Int Rev Immunol 1990; 6: 207-221.
10. Galanos C., Freudenberg M.A., Matsuura M., Coumbos A. Hypersensitivity to endotoxin and mechanisms of host-response. Prog Clin Biol Res 1988; 272: 295-308.
11. Lehmann V., Freudenberg M.A., Galanos C. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J Exp Med 1987; 165: 657-663.
12. Kumazawa Y., Matsuura M., Homma J.Y.et al.Immunopharmacological activities of 2-keto-3-deoxyoctonic acid-(α2→6)-linked 4-O-phosphono-D-glucosamine derivatives carrying N- and 3-O-acyl substituents. Infect Immun 1989; 57: 1845-1848.
13. Gallay P., Carrel S., Glauser M.P.et al.Purification and characterization of murine lipopolysaccharide-binding protein. Infect Immun 1993; 61: 378-383.
14. Tamura H., Tanaka S., Obayashi T., Yoshida M., Kawai T. A new sensitive microplate assay of plasma endotoxin. J Clin Lab Anal 1992; 6: 232-238.
15. Morita H., Urashima Y., Tanaka S., Aketagawa J., Tamura H., Kumazawa Y. Simultaneous estimation of endotoxin and (1→3)-β-D-glucan with an automated kinetic-chromogenic assay using Wellreader. J Antibact Antifung Agents 1996; 24: 467-475.
16. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
17. Kumazawa Y., Freudenberg M. A., Hausmann C.et al.Formation of interferon-gamma and tumor necrosis factor in mice during Salmonella typhimurium infection. pathobiology 1991; 59: 194-196.
18. Musson R.A., Morrison D.C., Ulevitch R.J. Distribution of endotoxin (lipopolysaccharide) in the tissues of lipopolysaccharide-responsive and unresponsive mice. Infect Immun 1978; 21: 448-457.
19. Jack R.S., Fan X., Bernheiden M.et al.Lipopolysaccharide-binding protein is required to combat a murine Gram-negative bacterial infection. Nature 1997; 389: 742-745.
20. Freudenberg M.A., Kumazawa Y., Meding S., Langhorne J., Galanos C. Gamma interferon production in endotoxin-responder and nonresponder mice during infection. Infect Immun 1991; 59: 3484-3491.
21. Tsutsui H., Matsui K., Kawada N.et al.IL-18 accounts for both TNFα- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J Immunol 1997; 159: 3961-3997.
22. Matsui K., Yoshimoto T., Tsutsui H.et al.Propionibacterium acnes treatment diminishes CD4+NK1.1+ T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells. J Immunol 1997; 159: 97-106.
23. Tanaka Y., Takahashi A., Watanabe K.et al.A pivotal role of IL-12 in Th1-dependent mouse liver injury. Int Immunol 1996; 8: 569-576.
24. Ghayur T., Banerjee S., Hugunin M.et al.Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production. Nature 1997; 386: 619-623.
25. Kohno K., Kataoka J., Otsuki T.et al.IFN-γ-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J Immunol 1997; 158: 1541-1450.
26. Micallef M.J., Ohtsuki T., Kohno K.et al.Interferon-γ-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for inteferon-y production. Eur J Immunol 1996; 26: 1647-1651.
27. Okamura H., Tsutui H., Komatsu T.et al.Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 1995; 378: 88-91.